COVID-19 and the Neuro-Oncology Community

SNO COVID-19 Task Force

As the global medical community and the world come together to face the challenges of COVID-19, the Society for Neuro-Oncololgy has established the COVID Task Force to address the needs of the Society’s membership and the neuro-oncology community. The Task Force’s mandate is to identify, develop, and disseminate guidance and educational resources specific to COVID-19 and the treatment and research of brain tumors.

COVID-19 Education and Updates

COVID-19 Neuro-Oncology Survey

The goals of the survey are as follows:

  • To understand how this global event has affected our patients and the neuro-oncology community
  • To gather comprehensive information about the pandemic and its effects on your clinical practice, your research projects, and your professional and personal life 
  • To understand member needs and how we can use the information to benefit our patients and our community in the future.    
This survey will take approximately 10 minutes to complete. The data will be shared with the SNO membership and wider readership through publications and other media.   Click here to take the survey.

Patient and Caregiver Fact Sheet

SNO appreciates that brain tumor patients are already dealing with distress and uncertainty, and that the pandemic is adding to these. A Fact sheet has been developed by SNO to provide information specific to brain tumor patients, caregivers and advocates. Please share this Fact Sheet with your patients and their families. To download the pdf Fact Sheet, click here.


Covid-19 and the Brain Tumour Community
Original Air Date: Wednesday, April 22, 2020

The International Brain Tumour Alliance (IBTA) and the Society for Neuro-Oncology encourage you to direct your patients, caregivers and advocates to register for a complimentary webinar during which neuro-oncology experts will provide answers on how the COVID-19 pandemic may be affecting them.  To view this webinar, click here.

Upcoming Webinar: Wednesday, June 3, 2020, at 1 PM EST

This Pandemic Isn’t Making My Burnout Better: A Systematic Approach to Coping During Covid-19

  • Dan Shapiro, MS, PhD, Vice Dean for Faculty and Administrative Affairs, Penn State College of Medicine, Principal: Burnout Solutions Group DES Health Consulting
  • Alvina Acquaye, MS, LCPC [c], Bio-Behavioral Research Associate, National Cancer Institute, Columbus Technologies & Services, Inc., Neuro-Oncology Branch

Journal Resources

Journal of Neuro-Oncology

Other Resources

Patient Advocacy Materials

Wellness Resources
(Resources collected by the SNO Wellness Committee)

Wellness videos from NCI Neuro-Oncology Branch

SNO Conferences

SNO has three conferences planned for later this year: Brain Metastases in Toronto, Canada (August 2020), Brain Tumor Metabolism in Bethesda, Maryland (October 2020), and our Annual Meeting in Austin, Texas (November 2020). At present, we are planning to hold these conferences as planned.

Ultimately, the health and safety of our registrants, partners, and SNO staff remain our main concern. We will continue to follow guidance and recommended safety measures from the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO).

SNO COVID-19 Task Force Members

  • Alvina Acquaye, National Institutes of Health (NIH)
  • Sameer Agnihotri, University of Pittsburgh
  • Terri Armstrong, National Institutes of Health (NIH)
  • Nicholas Butowski, University of California San Francisco
  • Susan Chang, University of California San Francisco
  • Milan Chheda, Washington University School of Medicine in St. Louis
  • Erin Dunbar, Piedmont Atlanta Hospital
  • Charles Haynes, Society for Neuro-Oncology
  • Monika Hegi, Lausanne University Hospital (CHUV)
  • Shawn Hervey-Jumper, University of California San Francisco
  • Michael Lim, Johns Hopkins University School of Medicine
  • Alireza Mansouri, Penn State Cancer Institute
  • Maciej Mrugala, Mayo Clinic
  • Farshad Nassiri, University of Toronto
  • Kathy Oliver, International Brain Tumour Alliance
  • Katherine Peters, Duke Cancer Center
  • Alyx Porter, Mayo Clinic
  • Shelley Pressley, Society for Neuro-Oncology
  • Joanne Salcido, Pediatric Brain Tumor Foundation
  • David Schiff, University of Virginia Health
  • Jennie Taylor, University of California San Francisco
  • Alissa Thomas, University of Vermont Medical Center
  • Martin van den Bent, Erasmus MC Cancer Center
  • Gelareh Zadeh, University Health Network

If you are interested in joining the Task Force, please contact